Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 873243, 7 pages
http://dx.doi.org/10.1155/2015/873243
Research Article

Flos Puerariae Extract Ameliorates Cognitive Impairment in Streptozotocin-Induced Diabetic Mice

1Xianning Hospital of Traditional Chinese Medicine, Xianning 437100, China
2Hubei Province Key Laboratory on Cardiovascular, Cerebrovascular, and Metabolic Disorders, Hubei University of Science and Technology, Xianning 437100, China

Received 13 January 2015; Revised 19 March 2015; Accepted 24 March 2015

Academic Editor: Thierry Hennebelle

Copyright © 2015 Zhong-he Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Prediabetes and the potential to prevent diabetes,” The Lancet, vol. 379, no. 9833, p. 2213, 2012. View at Publisher · View at Google Scholar
  2. A. Ott, R. P. Stolk, A. Hofman, F. van Harskamp, D. E. Grobbee, and M. M. B. Breteler, “Association of diabetes mellitus and dementia: the Rotterdam Study,” Diabetologia, vol. 39, no. 11, pp. 1392–1397, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. P. K. Elias, M. F. Elias, R. B. D'Agostino et al., “NIDDM and blood pressure as risk factors for poor cognitive performance: the Framingham Study,” Diabetes Care, vol. 20, no. 9, pp. 1388–1395, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Velayudhan, M. Poppe, N. Archer, P. Proitsi, R. G. Brown, and S. Lovestone, “Risk of developing dementia in people with diabetes and mild cognitive impairment,” The British Journal of Psychiatry, vol. 196, no. 1, pp. 36–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Raza, A. John, and F. C. Howarth, “Increased oxidative stress and mitochondrial dysfunction in zucker diabetic rat liver and brain,” Cellular Physiology and Biochemistry, vol. 35, pp. 1241–1251, 2015. View at Publisher · View at Google Scholar
  6. Q. Liu, F. Xie, R. Rolston et al., “Prevention and treatment of Alzheimer disease and aging: antioxidants,” Mini-Reviews in Medicinal Chemistry, vol. 7, no. 2, pp. 171–180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. Payne, S. Kaja, Y. Naumchuk, N. Kunjukunju, and P. Koulen, “Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina,” International Journal of Molecular Sciences, vol. 15, no. 2, pp. 1865–1886, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. P. Zhang, S. Y. Shi, X. Xiong, X. Q. Chen, and M. J. Peng, “Comparative evaluation of three methods based on high-performance liquid chromatography analysis combined with a 2,2′-diphenyl-1-picrylhydrazyl assay for the rapid screening of antioxidants from Pueraria lobata flowers,” Analytical and Bioanalytical Chemistry, vol. 402, no. 9, pp. 2965–2976, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Kamiya, A. Takano, Y. Matsuzuka et al., “Consumption of Pueraria flower extract reduces body mass index via a decrease in the visceral fat area in obese humans,” Bioscience, Biotechnology and Biochemistry, vol. 76, no. 8, pp. 1511–1517, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Chen, F. Cai, S. Guo et al., “Protective effect of Flos puerariae extract following acute alcohol intoxication in mice,” Alcoholism: Clinical and Experimental Research, vol. 38, no. 7, pp. 1839–1846, 2014. View at Publisher · View at Google Scholar
  11. F. Cai, X. Chen, Q. J. Chen et al., “Orthogonal test design for optimizing the extraction of total flavonoids from Flos pueraria,” African Journal of Pharmacy and Pharmacology, vol. 8, no. 1, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  12. K. Amirshahrokhi, A. R. Dehpour, J. Hadjati, M. Sotoudeh, and M. Ghazi-Khansari, “Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice,” Toxicology and Applied Pharmacology, vol. 232, no. 1, pp. 119–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. V. Vorhees and M. T. Williams, “Morris water maze: procedures for assessing spatial and related forms of learning and memory,” Nature Protocols, vol. 1, no. 2, pp. 848–858, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Agar, M. Bosnak, R. Amanvermez, S. Demir, M. Ayyildiz, and C. Celik, “The effect of ethanol on lipid peroxidation and glutathione level in the brain stem of rat,” NeuroReport, vol. 10, no. 8, pp. 1799–1801, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. McCord and I. Fridovich, “Superoxide dismutase: the first twenty years (1968–1988),” Free Radical Biology & Medicine, vol. 5, no. 5-6, pp. 363–369, 1988. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Derouiche, C. Bôle-Feysot, D. Naïmi, and M. Coëffier, “Hyperhomocysteinemia-induced oxidative stress differentially alters proteasome composition and activities in heart and aorta,” Biochemical and Biophysical Research Communications, vol. 452, no. 3, pp. 740–745, 2014. View at Publisher · View at Google Scholar
  17. D. Armstrong and R. Browne, “The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory,” Advances in Experimental Medicine and Biology, vol. 366, pp. 43–58, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. J. E. Noble and M. J. A. Bailey, “Quantitation of protein,” Methods in Enzymology, vol. 463, pp. 73–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Lenzen, “The mechanisms of alloxan- and streptozotocin-induced diabetes,” Diabetologia, vol. 51, no. 2, pp. 216–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Elsner, B. Guldbakke, M. Tiedge, R. Munday, and S. Lenzen, “Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin,” Diabetologia, vol. 43, no. 12, pp. 1528–1533, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Hoyer, S. A. E. Kyung Lee, T. Löffler, and R. Schliebs, “Inhibition of the neuronal insulin receptor: an in vivo model for sporadic Alzheimer disease?” Annals of the New York Academy of Sciences, vol. 920, pp. 256–258, 2000. View at Google Scholar · View at Scopus
  22. W. L. Xu, E. von Strauss, C. X. Qiu, B. Winblad, and L. Fratiglioni, “Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study,” Diabetologia, vol. 52, no. 6, pp. 1031–1039, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Janson, T. Laedtke, J. E. Parisi, P. O'Brien, R. C. Petersen, and P. C. Butler, “Increased risk of type 2 diabetes in Alzheimer disease,” Diabetes, vol. 53, no. 2, pp. 474–481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. I. V. J. Murray, J. F. Proza, F. Sohrabji, and J. M. Lawler, “Vascular and metabolic dysfunction in Alzheimer's disease: a review,” Experimental Biology and Medicine, vol. 236, no. 7, pp. 772–782, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. B. J. Clodfelder-Miller, A. A. Zmijewska, G. V. W. Johnson, and R. S. Jope, “Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency,” Diabetes, vol. 55, no. 12, pp. 3320–3325, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Kumari, E. Brunner, and R. Fuhrer, “Minireview: mechanisms by which the metabolic syndrome and diabetes impair memory,” The Journals of Gerontology—Series A Biological Sciences and Medical Sciences, vol. 55, no. 5, pp. B228–B232, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. O. Lorenzo, E. Ramírez, B. Picatoste, J. Egido, and J. Tuñón, “Alteration of energy substrates and ROS production in diabetic cardiomyopathy,” Mediators of Inflammation, vol. 2013, Article ID 461967, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Yu, W. Zha, S. Guo, H. Cheng, J. Wu, and C. Liu, “Flos puerariae extract prevents myocardial apoptosis via attenuation oxidative stress in streptozotocin-induced diabetic mice,” PLoS ONE, vol. 9, no. 5, Article ID e98044, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Colombres, J. P. Sagal, and N. C. Inestrosa, “An overview of the current and novel drugs for Alzheimer's disease with particular reference to anti-cholinesterase compounds,” Current Pharmaceutical Design, vol. 10, no. 25, pp. 3121–3130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Schliebs and T. Arendt, “The cholinergic system in aging and neuronal degeneration,” Behavioural Brain Research, vol. 221, no. 2, pp. 555–563, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Chen and C. Zhong, “Oxidative stress in Alzheimer's disease,” Neuroscience Bulletin, vol. 30, no. 2, pp. 271–281, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Rice-Evans, “Plant polyphenols: free radical scavengers or chain-breaking antioxidants?” Biochemical Society Symposium, vol. 61, pp. 103–116, 1995. View at Google Scholar · View at Scopus